Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Sales (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Return on Sales for 4 consecutive years, with 0.09% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 2135.0% to 0.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.09% through Dec 2025, up 18.0% year-over-year, with the annual reading at 0.09% for FY2025, 18.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.09% at Century Therapeutics, down from 0.87% in the prior quarter.
  • The five-year high for Return on Sales was 21.26% in Q4 2024, with the low at 336.27% in Q2 2023.
  • Average Return on Sales over 4 years is 59.0%, with a median of 27.51% recorded in 2024.
  • The sharpest move saw Return on Sales plummeted -31408bps in 2023, then surged 29580bps in 2024.
  • Over 4 years, Return on Sales stood at 60.8% in 2022, then tumbled by -142bps to 147.01% in 2023, then skyrocketed by 114bps to 21.26% in 2024, then tumbled by -100bps to 0.09% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.09%, 0.87%, and 0.89% for Q4 2025, Q3 2025, and Q2 2025 respectively.